Is Ashwagandha Good for Adrenal Fatigue and Burnout?

You've been taking ashwagandha for months because someone told you it helps with adrenal fatigue, but you still wake up exhausted, your stress feels unmanaged, and you're not sure if the supplement is doing anything at all. The term "adrenal fatigue" gets thrown around constantly in wellness circles, but it's not a recognized medical diagnosis, and the science behind what ashwagandha actually does for stress and burnout is more specific than most supplement marketing suggests.

Burnout and chronic stress affect the hypothalamic-pituitary-adrenal axis, not just the adrenals in isolation. Superpower's baseline panel tests cortisol alongside inflammatory markers, thyroid function, and metabolic health to give you the full picture of how your body is responding to stress, not just a single snapshot.

Key Takeaways

• Adrenal fatigue isn't a medical diagnosis; HPA axis dysregulation is the accurate term.
• Ashwagandha lowers cortisol modestly in stressed populations, not in everyone who takes it.
• Most clinical trials use 300-600 mg daily of standardized root extract (2019 rct).
• Evidence is strongest for subjective stress reduction, weaker for objective HPA markers.
• Ashwagandha can raise thyroid hormone levels and interact with thyroid medications.
• Chronic high-dose use may suppress the HPA axis in some individuals.
• Testing cortisol before supplementing tells you whether you actually need it.

What Ashwagandha Actually Does in the Body

Ashwagandha (Withania somnifera) is a botanical adaptogen, meaning it's proposed to help the body resist stressors of various kinds. The active compounds are withanolides, a group of steroidal lactones concentrated in the root. These compounds interact with multiple signaling pathways, including the hypothalamic-pituitary-adrenal axis, GABA receptors, and inflammatory cascades.

The HPA axis is your body's central stress response system. When you encounter a stressor, the hypothalamus releases corticotropin-releasing hormone, which signals the pituitary to release adrenocorticotropic hormone, which then tells the adrenal glands to produce cortisol. Cortisol mobilizes energy, suppresses inflammation, and helps you respond to the stressor. In a healthy system, cortisol rises when needed and falls when the stressor resolves. In chronic stress, this feedback loop can become dysregulated, leading to persistently elevated or blunted cortisol patterns, along with symptoms like fatigue, poor sleep, difficulty concentrating, and immune dysfunction.

Ashwagandha appears to modulate this system by influencing cortisol secretion and possibly enhancing negative feedback at the level of the hypothalamus and pituitary. It also has GABAergic activity, meaning it may enhance the calming effects of GABA, the brain's primary inhibitory neurotransmitter. This dual action on the HPA axis and the GABAergic system is the mechanistic basis for its use in stress-related conditions.

The term "adrenal fatigue" suggests that the adrenal glands themselves are exhausted and unable to produce adequate cortisol. This is not supported by endocrinology. True adrenal insufficiency (Addison's disease) is a serious medical condition with measurably low cortisol and requires hormone replacement. What people describe as adrenal fatigue is more accurately HPA axis dysregulation, where the signaling between the brain and adrenals is disrupted, not the glands themselves.

What the Clinical Trials Actually Show on Ashwagandha and Stress

A 2019 randomized controlled trial published in Medicine found that 600 mg of ashwagandha root extract daily for eight weeks reduced serum cortisol by approximately 28% compared to placebo in adults with chronic stress. Participants also reported significant reductions in stress scores on validated scales like the Perceived Stress Scale and the Hamilton Anxiety Rating Scale. The effect was dose-dependent, with higher doses producing greater reductions in stress and anxiety. The study population was not selected for high stress, which is an important distinction; the cortisol-lowering effect appears to be more pronounced in individuals with elevated baseline stress or cortisol.

A 2021 systematic review and meta-analysis in the Journal of Ethnopharmacology examined 12 randomized controlled trials and found that ashwagandha significantly reduced cortisol levels and improved stress and anxiety scores compared to placebo. The review noted that the effect on cortisol was not consistent across all trials, and some studies found no significant change in cortisol despite improvements in subjective stress.

The evidence is strongest for subjective stress reduction in people who are already experiencing high stress. The cortisol-lowering effect is real but modest, and it does not appear to occur in individuals with normal baseline cortisol. Extrapolating these findings to "adrenal fatigue" is problematic because the studies did not measure adrenal function directly, and the populations studied were not diagnosed with adrenal insufficiency or HPA axis dysfunction using objective criteria.

How Ashwagandha Affects the HPA Axis and Cortisol Regulation

Withanolides, the active compounds in ashwagandha, have been shown in preclinical studies to influence the expression of genes involved in stress response and to enhance the sensitivity of glucocorticoid receptors, which are the receptors that cortisol binds to in order to exert its effects (2024 literature review). When glucocorticoid receptors in the hypothalamus and pituitary are more sensitive, they respond more effectively to circulating cortisol, which strengthens the negative feedback loop that shuts down cortisol production when levels are adequate.

Ashwagandha also has GABAergic activity, meaning it enhances the activity of GABA, the brain's primary inhibitory neurotransmitter. GABA reduces neuronal excitability and has a calming effect on the nervous system. By enhancing GABAergic tone, ashwagandha may reduce the perception of stress and the activation of the HPA axis in response to stressors. This is mechanistically similar to how benzodiazepines work, though ashwagandha's effect is much milder.

There is also evidence that ashwagandha has anti-inflammatory effects, which may indirectly support HPA axis function. Chronic inflammation can dysregulate the HPA axis by interfering with glucocorticoid receptor signaling and by increasing the production of pro-inflammatory cytokines that stimulate cortisol release. By reducing inflammation, ashwagandha may help restore more normal HPA axis function.

However, there are case reports suggesting that chronic use may suppress the HPA axis in some individuals. A 2021 case report in the Journal of Clinical Endocrinology described a patient who developed biochemical adrenal insufficiency after taking ashwagandha for several months, which resolved after discontinuation. Another case report from 2022 described adrenal hypofunction associated with ten weeks of ashwagandha supplementation, which was reversible after a two-week break. These cases suggest that ashwagandha's cortisol-lowering effect can, in some individuals, become excessive, leading to suppression of the HPA axis rather than normalization.

GABA receptor modulation and anxiolytic effects

Ashwagandha's GABAergic activity is thought to contribute to its anxiolytic (anxiety-reducing) effects. GABA is the brain's primary inhibitory neurotransmitter, and enhancing GABA activity reduces neuronal excitability, which produces a calming effect. This is the same mechanism by which benzodiazepines and alcohol work, though ashwagandha's effect is much milder and does not carry the same risk of dependence or sedation.

Glucocorticoid receptor sensitivity and negative feedback

Ashwagandha may enhance the sensitivity of glucocorticoid receptors, which are the receptors that cortisol binds to in order to exert its effects. When these receptors are more sensitive, the body responds more effectively to circulating cortisol, which strengthens the negative feedback loop that shuts down cortisol production when levels are adequate.

Dose, Form, and Timing: What the Evidence Supports

Most clinical trials have used standardized root extracts, not raw ashwagandha powder. The two most commonly studied extracts are KSM-66 and Sensoril. KSM-66 is a full-spectrum root extract standardized to contain at least 5% withanolides, produced using a water-based extraction process. Sensoril is a root and leaf extract standardized to contain 10% withanolides and 32% oligosaccharides, produced using a different extraction method. Both have been used in clinical trials with positive results, but they are not interchangeable; the withanolide profile and bioavailability differ between the two. KSM-66 has been studied more extensively in the context of stress and cortisol reduction, while Sensoril has been studied more in the context of anxiety and cognitive function. If you are choosing an ashwagandha supplement, look for one that specifies the extract used and the withanolide content.

The most commonly studied dose range is 300-600 mg daily of standardized extract (2020 meta-analysis). The 2019 study that found significant cortisol reduction used 600 mg once daily. There is some evidence of a dose-dependent effect, with higher doses producing greater reductions in stress and cortisol, but doses above 600 mg daily have not been extensively studied for safety (2019 rct). No formal tolerable upper intake level has been established for ashwagandha, but higher doses have been associated with increased gastrointestinal side effects.

Ashwagandha can be taken at any time of day, but some people find it mildly sedating and prefer to take it in the evening. If you are taking it for stress reduction, splitting the dose into morning and evening may provide more consistent coverage throughout the day. If you are taking it for sleep, taking the full dose in the evening may be more effective. There is no strong evidence that timing significantly affects efficacy, so this is largely a matter of personal preference and tolerance.

Some studies have combined ashwagandha with other adaptogens or nutrients. A 2020 study combined ashwagandha with rhodiola and B vitamins and found improvements in stress and fatigue. However, it is not clear whether the combination was more effective than ashwagandha alone, as the study did not include an ashwagandha-only arm.

Who Responds Best to Ashwagandha, and Who Should Exercise Caution

Ashwagandha is most likely to benefit individuals with elevated baseline stress and cortisol. The clinical trials that found significant cortisol reductions enrolled participants with chronic stress, as measured by validated stress scales. If your cortisol is already low or normal, ashwagandha is unlikely to produce a meaningful benefit and may, in some cases, suppress cortisol further.

Ashwagandha has been shown to increase thyroid hormone levels in some studies, which may be beneficial for people with subclinical hypothyroidism but problematic for people with normal or elevated thyroid function (2017 rct). If you are taking levothyroxine or another thyroid medication, ashwagandha may alter your thyroid hormone levels, requiring dose adjustments. Ashwagandha may interact with sedatives, including benzodiazepines, barbiturates, and alcohol, because of its GABAergic activity. Taking ashwagandha with these substances may increase sedation and impair cognitive function. It may also interact with immunosuppressants, as ashwagandha has immune-modulating effects that could theoretically counteract immunosuppressive therapy.

Ashwagandha is not recommended for people who are pregnant or breastfeeding, as there is insufficient safety data. It is also not recommended for people with autoimmune conditions, as it may stimulate the immune system, though the evidence on this is mixed. People with a history of stomach ulcers should use caution, as ashwagandha may irritate the gastrointestinal lining in some individuals. The case reports of adrenal suppression suggest that chronic, high-dose use may be problematic for some individuals. If you are taking ashwagandha long-term, it may be prudent to cycle off periodically or to monitor cortisol levels to ensure that the HPA axis is not being suppressed.

Testing Your Stress Response: What Biomarkers Tell You About HPA Function

If you are considering ashwagandha for stress or burnout, testing your cortisol and related markers before you start supplementing gives you an objective baseline. Serum cortisol is the most commonly measured marker, but it is highly variable and depends on the time of day, recent stress, and other factors. A single morning cortisol measurement can tell you whether your levels are grossly abnormal, but it does not give you a complete picture of HPA axis function.

A more informative approach is to measure cortisol in the context of other markers that reflect stress, inflammation, and metabolic health:

• High-sensitivity C-reactive protein is a marker of systemic inflammation, which can dysregulate the HPA axis.
• Thyroid-stimulating hormone, T4, and free T3 tell you whether thyroid function is contributing to fatigue or stress intolerance.
• Fasting glucose and insulin tell you whether metabolic dysregulation is affecting your energy and stress resilience.

If you are taking ashwagandha and want to know whether it is working, retesting cortisol after 8-12 weeks can tell you whether your levels have changed. However, cortisol is only one piece of the puzzle. Subjective measures of stress, sleep quality, and energy are also important, and they may improve even if cortisol does not change significantly.

For individuals with suspected HPA axis dysregulation, more advanced testing may be warranted. A four-point salivary cortisol test measures cortisol at four times throughout the day (morning, midday, evening, and night) and gives you a picture of your diurnal cortisol rhythm. This can reveal patterns like blunted morning cortisol, elevated evening cortisol, or a flattened curve, all of which are associated with chronic stress and burnout (2017 meta-analysis). However, salivary cortisol testing is not standardized, and interpretation can be challenging.

ACTH stimulation testing is the gold standard for diagnosing adrenal insufficiency, but it is not routinely used for HPA axis dysregulation because the condition is not well-defined in clinical practice. If you have symptoms of severe fatigue, low blood pressure, and weight loss, and your morning cortisol is very low, ACTH stimulation testing may be appropriate to rule out Addison's disease.

Getting a Real Picture of Your Stress Biology

Ashwagandha is one of the more promising supplements for stress reduction, but whether it is the right tool for you depends on where your cortisol, inflammation, and metabolic markers actually sit. Most people supplementing ashwagandha are dosing blind, without knowing whether their cortisol is high, low, or normal, and without understanding the broader context of their stress biology. Superpower's 100+ biomarker panel includes cortisol, hsCRP, thyroid function, glucose, insulin, and the full metabolic and inflammatory picture that determines how your body responds to stress. Testing before you supplement transforms a guessing game into a personalized protocol, and retesting after 8-12 weeks tells you whether the intervention is actually working or whether you need a different approach.